Company Filing History:
Years Active: 1991
Title: The Innovations of James L. Gaylor
Introduction
James L. Gaylor is a notable inventor based in Skillman, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroid derivatives that serve as hypocholesterolemics. With a total of 2 patents to his name, Gaylor's work has had a meaningful impact on cholesterol management.
Latest Patents
Gaylor's latest patents focus on steroid derivatives that are effective in lowering cholesterol levels. These patents detail lanosterols substituted in the 14 and/or 15 positions, which are active in inhibiting lanosta-8,24-dien-3.beta.-ol 14.alpha.-methyl-demethylase activity. Additionally, they suppress 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity, thereby decreasing cholesterol synthesis and reducing serum cholesterol levels.
Career Highlights
James L. Gaylor is currently associated with E.I. du Pont de Nemours and Company, where he continues to innovate in the field of biochemistry. His work has been instrumental in advancing therapeutic options for individuals dealing with high cholesterol.
Collaborations
Gaylor has collaborated with several esteemed colleagues, including Paul R. Johnson and Soo Sung Ko. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
James L. Gaylor's contributions to the field of pharmaceuticals, particularly in cholesterol management, highlight his innovative spirit and dedication to improving health outcomes. His patents and collaborations reflect a commitment to advancing medical science.